Bioequivalence Study of ICI176,334-1 in Japanese Healthy Male Subjects - Evaluation of Bioequivalence of ICI176,334-1 and Casodex 80 mg Tablet.

Trial Profile

Bioequivalence Study of ICI176,334-1 in Japanese Healthy Male Subjects - Evaluation of Bioequivalence of ICI176,334-1 and Casodex 80 mg Tablet.

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Feb 2012

At a glance

  • Drugs Bicalutamide (Primary)
  • Indications Prostate cancer
  • Focus Pharmacokinetics
  • Sponsors AstraZeneca
  • Most Recent Events

    • 29 Feb 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
    • 29 Feb 2012 Actual initiation date (Aug 2011) added as reported by ClinicalTrials.gov.
    • 29 Feb 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top